MET - MetLife, Inc.
NYSE
->
Financial Services
->
Insurance—Life
New York,
United States
Type: Equity
MET price evolution
MET
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $20639 | $14912 | $15417 | $18456 |
| Short term investments | ||||
| Net receivables | $28971 | $19002 | $18530 | $18692 |
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | $9236 | $9109 | $9261 | $9379 |
| Total noncurrent assets | ||||
| Total investments | $446137 | $435662 | $450948 | $441302 |
| Total assets | $687584 | $652120 | $677279 | $674266 |
| Current liabilities | ||||
| Accounts payable | $17524 | $17797 | $18806 | $19863 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $505 | $601 | $566 | $1078 |
| Long term debt | $18709 | $18635 | $17699 | $17781 |
| Total noncurrent liabilities | ||||
| Total debt | $19465 | $19447 | $18574 | $18653 |
| Total liabilities | $657569 | $626225 | $646787 | $641843 |
| Shareholders' equity | ||||
| Retained earnings | $40146 | $39958 | $39928 | $39957 |
| Other shareholder equity | -$19242 | -$24254 | -$20386 | -$19147 |
| Total shareholder equity | $30015 | $25658 | $30261 | $32194 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $20639 | $20195 | $20047 | $19795 |
| Short term investments | ||||
| Net receivables | $28971 | $17461 | $17149 | $17870 |
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | $3561 | $1861 | $2210 | $2614 |
| Goodwill & intangible assets | $9236 | $9297 | $9535 | $10112 |
| Total noncurrent assets | ||||
| Total investments | $446137 | $433293 | $494821 | $508519 |
| Total assets | $687584 | $666611 | $759708 | $795146 |
| Current liabilities | ||||
| Accounts payable | $17524 | $20937 | $31920 | $29475 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $505 | $562 | $3796 | $5548 |
| Long term debt | $18709 | $17805 | $17089 | $15448 |
| Total noncurrent liabilities | ||||
| Total debt | $19465 | $18696 | $18196 | $18994 |
| Total liabilities | $657569 | $639571 | $691959 | $720329 |
| Shareholders' equity | ||||
| Retained earnings | $40146 | $41953 | $41197 | $36491 |
| Other shareholder equity | -$19242 | -$27083 | $10919 | $18072 |
| Total shareholder equity | $30015 | $27040 | $67482 | $74558 |
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $19028 | $16623 | $15388 | |
| Cost of revenue | $13060 | $12074 | ||
| Gross Profit | $3563 | $3314 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $17818 | $3133 | $3057 | |
| Operating income | $430 | $257 | ||
| Income from continuing operations | ||||
| EBIT | $424 | $252 | ||
| Income tax expense | $327 | $22 | $172 | |
| Interest expense | -$269 | |||
| Net income | ||||
| Net income | $574 | $402 | $80 | |
| Income (for common shares) | $370 | $14 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $66905 | $69898 | $71080 | $67842 |
| Cost of revenue | $55005 | $50368 | $47765 | |
| Gross Profit | $14893 | $20712 | $20077 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $63698 | $12034 | $12586 | $13150 |
| Operating income | $2859 | $8126 | $6927 | |
| Income from continuing operations | ||||
| EBIT | $2840 | $8105 | $6916 | |
| Income tax expense | $560 | $301 | $1551 | $1509 |
| Interest expense | -$1045 | |||
| Net income | ||||
| Net income | $1380 | $2539 | $6554 | $5407 |
| Income (for common shares) | $2354 | $6353 | $5191 | |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $607 | $489 | $402 | $80 |
| Operating activities | ||||
| Depreciation | $718 | |||
| Business acquisitions & disposals | -$131 | -$304 | -$246 | -$233 |
| Stock-based compensation | ||||
| Total cash flows from operations | $5182 | $3475 | $3038 | $2026 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | $725 | -$2650 | -$6090 | -$1174 |
| Total cash flows from investing | $576 | -$2972 | -$6346 | -$1504 |
| Financing activities | ||||
| Dividends paid | -$386 | -$392 | -$399 | -$389 |
| Sale and purchase of stock | -$859 | -$792 | -$672 | -$780 |
| Net borrowings | $186 | $972 | -$699 | -$24 |
| Total cash flows from financing | -$176 | -$848 | $379 | -$2295 |
| Effect of exchange rate | $145 | -$160 | -$110 | $34 |
| Change in cash and equivalents | $5727 | -$505 | -$3039 | -$1739 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1578 | $2539 | $6554 | $5407 |
| Operating activities | ||||
| Depreciation | $718 | $673 | $694 | $619 |
| Business acquisitions & disposals | -$914 | $203 | $3180 | -$2851 |
| Stock-based compensation | ||||
| Total cash flows from operations | $13721 | $13204 | $12596 | $11639 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | -$9189 | -$2795 | -$14321 | -$15857 |
| Total cash flows from investing | -$10246 | -$2620 | -$11187 | -$18569 |
| Financing activities | ||||
| Dividends paid | -$1566 | -$1598 | -$1647 | -$1657 |
| Sale and purchase of stock | -$3103 | -$3326 | -$4303 | -$1151 |
| Net borrowings | $712 | $878 | -$632 | $877 |
| Total cash flows from financing | -$2940 | -$10108 | -$1375 | $10729 |
| Effect of exchange rate | -$91 | -$397 | -$478 | $163 |
| Change in cash and equivalents | $444 | $79 | -$444 | $3962 |
News
Fundamentals
| Market cap | $51.97B |
|---|---|
| Enterprise value | $50.79B |
| Shares outstanding | 730.80M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 16.62% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 1.06 |
| Book/Share | 67.40 |
| Cash/Share | 28.24 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 21.91 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |